Clinical Study Results
Where can I learn more about this study?
You can find more information about this study on the websites listed below. If a full report
of the study results is available, it can also be found here.
• www.clinicaltrials.gov Once you are on this website, type “NCT02599714” into the
search box and click “Search”.
• www.clinicaltrialsregister.eu Once you are on the website, click “Home and
Search”, then type “2015-003320-30” in the search box and click “Search”.
• www.AstraZenecaClinicalTrials.com. Once you are on the website, type
“D2270C00020” into the search box and click “Find a Study”.
Full Trial Title: A Phase I/II Multicenter Study of the Combination of AZD2014
and Palbociclib on a background of Hormonal Therapy in Patients with Locally
Advanced/Metastatic Estrogen Receptor Positive Breast Cancer Comprising a Safety,
Pharmacokinetic and Preliminary Efficacy Evaluation followed by a Randomized,
Double-Blind, Placebo-controlled, Parallel Group Extension (PASTOR)
National Clinical Trials number: NCT02599714
AstraZeneca Protocol Number: D2270C00020
AstraZeneca AB sponsored this study and has its headquarters in Södertälje, Sweden.
The phone number for the AstraZeneca Information Center is +1 877 240 9479.
Thank you!
Clinical study participants belong to a large community of people who take part in clinical
research around the world. They help researchers answer important health questions
and find medical treatments for participants.
The Center for Information & Study on Clinical Research
Participation (CISCRP) is a non-profit organization focused
on educating and informing the public about clinical research
participation. CISCRP is not involved in recruiting participants for
clinical studies, nor is it involved in conducting clinical studies.
CISCRP
One Liberty Square, Suite 1100 • Boston, MA 02109
1-877-MED-HERO • www.ciscrp.org
Version 1.0 2020_01_08 12